1. The cap raising.
Do not whinge if this is at a price of 28c to 30c. The share price had been knocked down at the end of each day recently. I expect the raising will be at a bit of a "mates rates" discount to recent closing prices but not so much as the ugly one last year. If you want to be one of the "mates", get on the phone although chances are you will be already too late. You need to have funds ready to transfer and be a sophisticated investor.
2. Plant expansion.
Part of the start up issues almost certainly relate to the nuggety gold. They may or may not already have a gravity plant on the front end. This was one of my concerns last year. Rumour said they did but there was never an announcement. Depending on ore characteristics, they may be able to triple plant output with a combination of in line pressure jigs and a rotary high temperature digester. Cost about $3M new I expect. Plenty of other options as well.
3. Gold Pour.
I'm sticking by my 60kg estimate and hoping like hell they will pour three times as much.
- Forums
- ASX - By Stock
- AAM
- Ann: Trading Halt
Ann: Trading Halt , page-45
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AAM (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
-0.003(5.08%) |
Mkt cap ! $29.44M |
Open | High | Low | Value | Volume |
5.9¢ | 6.1¢ | 5.6¢ | $9.671K | 169K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26672 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 24995 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26672 | 0.056 |
2 | 157272 | 0.055 |
3 | 407562 | 0.054 |
1 | 157435 | 0.053 |
2 | 159068 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 24995 | 1 |
0.062 | 15000 | 1 |
0.065 | 94262 | 1 |
0.066 | 42833 | 2 |
0.067 | 20000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AAM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online